wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q50273353-2F2C856E-104F-48B6-8A04-E63905BBEAA6
Q50273353-2F2C856E-104F-48B6-8A04-E63905BBEAA6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50273353-2F2C856E-104F-48B6-8A04-E63905BBEAA6
RhEPO improves time to exhaustion by non-hematopoietic factors in humans.
P2860
Q50273353-2F2C856E-104F-48B6-8A04-E63905BBEAA6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50273353-2F2C856E-104F-48B6-8A04-E63905BBEAA6
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b765db781fc6d83713af3cfc83c6209c36acfc47
P2860
Prolonged administration of recombinant human erythropoietin increases submaximal performance more than maximal aerobic capacity.